NCT06670079View on ClinicalTrials.gov

Prolonged Exposure Therapy to Treat Posttraumatic Stress Disorder in Pregnant Patients Receiving Medications for Opioid Use Disorder

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

April 30, 2027

Conditions
Posttraumatic Stress DisorderOpioid Use DisorderPregnancy
Interventions
BEHAVIORAL

Prolonged exposure therapy + incentives for therapy session attendance

Prolonged exposure therapy plus incentives for therapy session attendance

Trial Locations (1)

05401

University of Vermont, Burlington

All Listed Sponsors
lead

University of Vermont

OTHER

NCT06670079 - Prolonged Exposure Therapy to Treat Posttraumatic Stress Disorder in Pregnant Patients Receiving Medications for Opioid Use Disorder | Biotech Hunter | Biotech Hunter